|
Compound
|
Virgin
|
Parous
|
|---|
|
Control
|
Supplementary
|
Control
|
Supplementary
|
|---|
|
DA (ng/g)
|
6.3 ± 0.8
|
5.0 ± 0.7
|
4.2 ± 0.4#
|
3.6 ± 0.5#
|
|
DOPAC (ng/g)
|
3.1 ± 0.5
|
2.0 ± 0.2
|
3.1 ± 0.7
|
3.5 ± 0.7
|
|
HVA (ng/g)
|
0.5 ± 0.1
|
0.4 ± 0.1
|
0.3 ± 0.0
|
0.4 ± 0.1
|
|
NE (ng/g)
|
3.8 ± 0.4
|
3.5 ± 0.5
|
2.7 ± 0.3
|
3.0 ± 0.3
|
|
MHPG (ng/g)
|
0.4 ± 0.0
|
0.3 ± 0.0
|
0.3 ± 0.0
|
0.3 ± 0.0
|
|
VMA(ng/g)
|
4.0 ± 0.3
|
3.5 ± 0.7
|
4.5 ± 0.4
|
3.5 ± 0.4
|
|
TRY (ug/g)
|
4.8 ± 0.3
|
4.0 ± 0.1
|
3.7 ± 0.1
|
4.6 ± 0.4
|
|
5-HT (ng/g)
|
129.6 ± 17.9
|
105.5 ± 14.0
|
108.1 ± 9.1
|
121.1 ± 12.3
|
|
5-HIAA (ng/g)
|
194.5 ± 30.3
|
166.8 ± 29.6
|
123.4 ± 9.5
|
71.8 ± 14.1##
|
|
5-HIAA/5-HT
|
1.8 ± 0.5
|
2.3 ± 0.6
|
0.7 ± 0.1
|
0.7 ± 0.2#
|
|
KYN (ng/g)
|
282.6 ± 24.5
|
242.4 ± 6.9
|
222.8 ± 8.8
|
239.3 ± 14.4
|
|
GABA (ug/g)
|
63.3 ± 5.0
|
49.5 ± 3.1
|
31.6 ± 1.5##
|
34.4 ± 1.5
|
|
GLU (ug/g)
|
0.1 ± 0.0
|
0.1 ± 0.0
|
0.1 ± 0.0
|
0.1 ± 0.0
|
|
GLN (ug/g)
|
48.3 ± 3.7
|
38.0 ± 3.7
|
29.2 ± 1.3##
|
32.5 ± 1.1
|
- Data are means ± SEM (n = 6–7). #p < 0.05, ##p < 0.01 compared to virgin group; *p < 0.05, **p < 0.01compared to control group
